Status:
COMPLETED
Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment
Lead Sponsor:
Retina Institute of Hawaii
Conditions:
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
The use of Indocyanine green diagnostic dye will identify areas of vascular leakage which will provide more effective laser treatment by targeting these specific areas.
Detailed Description
The Early Treatment of Diabetic Retinopathy Study showed that early treatment of Clinically Significant Macular Edema (CSME) with focal and grid laser preserved vision in diabetic patients. Indocyanin...
Eligibility Criteria
Inclusion
- Meets criteria for Clinically Significant Macular Edema
- Microaneurysms hyperfluorescent
Exclusion
- Increase intraocular pressure
- Intraocular inflammation
- Retinal detachment
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01792141
Start Date
January 1 2011
End Date
December 1 2012
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina Institute of Hawaii
Honolulu, Hawaii, United States, 96815